Form 4: RBC Bearings Director Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


RBC Bearings Director Steven H. Kaplan reported exercising options and subsequently selling 700 shares of common stock on November 12, 2025, reducing his direct beneficial ownership to 1,999 shares.

Summary

  • Director Steven H. Kaplan engaged in transactions involving RBC Bearings common stock on November 12, 2025.
  • Kaplan exercised options to acquire 200 shares of common stock at an exercise price of $158.48 per share.
  • On the same date, he sold 200 shares of common stock at $443.35 per share and an additional 500 shares at $442.86 per share.
  • Following these transactions, his direct beneficial ownership of common stock decreased from 2,699 shares to 1,999 shares.
  • The reported beneficial ownership of 1,999 shares includes 1,384 shares of restricted stock with various vesting schedules through May 30, 2028.
  • Kaplan also holds several tranches of options to purchase common stock with varying exercise prices and vesting schedules, including 400 options exercisable at $137.44, 1,000 options at $199.16, 1,000 options at $199.09, 1,000 options at $206.19, 974 options at $287.37, and 962 options at $365.87.

Sentiment

Score: 5

Explanation: The filing reports a director's exercise of stock options and subsequent sale of shares, which is a common practice for compensation realization and personal financial management. It does not inherently reflect positively or negatively on the company's operational performance or future prospects.

Positives

  • The director realized significant gains by selling shares at prices ($443.35 and $442.86) substantially higher than the option exercise price ($158.48).

Negatives

  • The sale of 700 shares by a director reduces his direct beneficial ownership, which could be interpreted by some investors as a lack of confidence, although it is often a routine compensation realization event.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may interpret the director's sale of shares as a signal, though such transactions are often routine for compensation realization and personal financial planning.
  • No direct impact on employees, customers, suppliers, or creditors is indicated by this specific filing.

Next Steps

  • Future vesting of remaining restricted stock and unexercised stock options according to their respective schedules.

Key Dates

DateDescription
06/03/2022Date exercisable for 1,000 options to purchase Common Stock at $199.16, with 200 options vesting on 06/03/2026.
06/06/2023Date exercisable for 1,000 options to purchase Common Stock at $199.09, with 400 options vesting 1/2 on 06/06/2026 and 1/2 on 06/06/2027.
06/02/2024Date exercisable for 400 options to purchase Common Stock at $137.44.
06/05/2024Date exercisable for 1,000 options to purchase Common Stock at $206.19, with 600 options vesting 1/3 on 06/05/2026, 1/3 on 06/05/2027, and 1/3 on 06/05/2028.
08/19/2024Date exercisable for 200 options to purchase Common Stock at $158.48.
05/29/2025Date exercisable for 974 options to purchase Common Stock at $287.37, with 779 options vesting 1/4 on 05/29/2026, 1/4 on 05/29/2027, 1/4 on 05/29/2028, and 1/4 on 05/29/2029.
11/12/2025Transaction date for option exercise and subsequent sale of common stock by Steven H. Kaplan.
05/29/2026Vesting date for 1/2 of 452 restricted shares and 1/4 of 779 options.
05/30/2026Vesting date for 1/3 of 532 restricted shares and 1/5 of 962 options; Date exercisable for 962 options to purchase Common Stock at $365.87.
06/03/2026Vesting date for 200 options to purchase Common Stock.
06/05/2026Vesting date for 400 restricted shares and 1/3 of 600 options.
06/06/2026Vesting date for 1/2 of 400 options to purchase Common Stock.
08/19/2026Expiration date for 200 options to purchase Common Stock at $158.48.
05/29/2027Vesting date for 1/2 of 452 restricted shares and 1/4 of 779 options.
05/30/2027Vesting date for 1/3 of 532 restricted shares and 1/5 of 962 options.
06/02/2027Expiration date for 400 options to purchase Common Stock at $137.44.
06/06/2027Vesting date for 1/2 of 400 options to purchase Common Stock.
05/29/2028Vesting date for 1/4 of 779 options.
05/30/2028Vesting date for 1/3 of 532 restricted shares and 1/5 of 962 options.
06/03/2028Expiration date for 1,000 options to purchase Common Stock at $199.16.
06/05/2028Vesting date for 1/3 of 600 options.
05/29/2029Vesting date for 1/4 of 779 options.
05/30/2029Vesting date for 1/5 of 962 options.
06/06/2029Expiration date for 1,000 options to purchase Common Stock at $199.09.
05/30/2030Vesting date for 1/5 of 962 options.
06/05/2030Expiration date for 1,000 options to purchase Common Stock at $206.19.
05/29/2031Expiration date for 974 options to purchase Common Stock at $287.37.
05/30/2032Expiration date for 962 options to purchase Common Stock at $365.87.

Recommendation

hold

The Form 4 filing details a routine insider transaction where a director exercised stock options and sold a portion of the acquired shares. This is a common practice for compensation realization and personal portfolio management and does not provide sufficient new information to warrant a change in investment recommendation based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

RBC Bearings, RBC, Steven H. Kaplan, Insider Trading, Form 4, Stock Options, Share Sale, Director Transactions, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.